Overview

Drawing upon nearly 25 years of experience as a patent agent, Dr. Jeff Anderson provides tailored guidance to bioscience, pharmaceutical, clinical diagnostic, and medical device companies in the development and management of their patent portfolios. His technical expertise includes drug chemistry, antibody engineering, imaging techniques, and the identification of nucleic acids, peptides, and small molecule markers, and extends across the following industries:

  • Biochemistry
  • Molecular and cellular biology
  • Diagnostics
  • Biosensor design
  • Surface chemistries
  • Histochemistry

Clients appreciate Dr. Anderson’s approach and deep understanding of complex issues, particularly in shaping prosecution strategies. He offers a valuable perspective blending technical expertise with business insight and acumen enabling him to create and execute effective intellectual property strategies. His experience leading in-house legal teams has equipped him to initiate and develop diverse patent portfolios and successfully manage licensing, financial, and IPO-related due diligence efforts.

Outside of work, he enjoys spending time with his wife and three kids, running, mountain biking, and surfing.

Education
  • Ph.D., Northwestern University,

    Biochemistry

  • B.S., University of California, Davis,

    Biochemistry

Bar Admissions
  • U.S. Patent & Trademark Office

Experience

  • Prepared and/or prosecuted over one thousand patent applications in over forty countries
  • Conducted freedom to operate and patentability analyses start-ups to Fortune 500 companies
  • Provided technical advice to clients on infringement, validity, and freedom to operate issues
  • Lead more than 20 IP due diligence efforts in support of business development, financing and strategic activities, including two IPOs
  • Working in-house for a start-up pharmaceutical company as Director of IP, lead worldwide IP strategy and grew the IP portfolio over 3x with a 1.4x budget
  • Working in-house for a start-up clinical diagnostics company as Director of IP, lead worldwide IP strategy and grew the IP portfolio 2.7x with a 1.2x budget
Search
Menu
Menu